Jeremy Ruskin, MD – Chairman
Founder and Director, Cardiac Arrhythmia Service, Massachusetts General Hospital
Dr. Ruskin is a world-renowned cardiologist and electrophysiologist. He is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Ruskin received his undergraduate degree from Tufts University and his medical degree from Harvard Medical School. He completed his residency in Internal Medicine at Beth Israel Hospital in Boston and his fellowship in Cardiovascular Disease at the Massachusetts General Hospital. He received his training in clinical and experimental cardiac electrophysiology at the USPHS Hospital in Staten Island, New York under the mentorship of Dr. Anthony Damato.
Dr. Ruskin has trained more than 110 fellows in the subspecialty of cardiac arrhythmias over the past 38 years, many of whom are in leadership positions at academic centers throughout the world. In addition, Dr Ruskin is a much sought after speaker at medical conferences and has authored more than 450 original scientific publications, chapters, reviews, and monographs. Dr. Ruskin’s major research interests include: the mechanisms and management of atrial fibrillation; new antiarrhythmic drugs and innovative non-pharmacologic approaches to the treatment of atrial fibrillation; the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death; the role of arrhythmia control devices in the prevention of sudden cardiac death; the proarrhythmic effects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development. In 1995, Dr. Ruskin founded the Annual International Atrial Fibrillation Symposium which he has directed since its inception and is the largest and longest running free-standing academic meeting on atrial fibrillation worldwide. Dr. Ruskin also maintains an active regional, national and international referral practice in the field of cardiac arrhythmias and electrophysiology and is recognized annually in Best Doctors in Boston and Best Doctors in America. He is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.
John Camm, MD, FRCP, FAC, FESC, FHRS
Professor of Clinical Cardiology, St. Georges University, London
Dr. Camm is a worldwide renowned clinical trialist and has held or holds memberships in 30 multicentre study committees and has given over 1,000 lectures to international audiences, written more than 1,000 peer reviewed papers, more than 500 book chapters and over 30 books. He is particularly interested in clinical cardiac electrophysiology, cardiac arrhythmias and implantable devices for rhythm control.
Dr. Camm is past Chairman of the Department of Cardiac and Vascular Sciences and is past Chairman of the Department of Medicine at St. George’s. He is also past Chairman of the European Society of Cardiology Working Group on Cardiac Arrhythmias, former Chairman of the of European Society of Cardiology Working Group on Arrhythmias, past President of the British Pacing & Electrophysiology Group, past President of the British Cardiovascular Society and a past council member of the Royal College of Physicians and a former Trustee of the North American Society of Pacing and Electrophysiology (now the Heart Rhythm Society). He is currently the President of the Arrhythmia Alliance, a trustee of the Atrial Fibrillation Association, the Drug Safety Research Unit, the American College of Cardiology and the Interventional Cardiac Pacing and Electrophysiology Society and Editor of Europace, the only European Journal devoted to cardiac electrophysiology and arrhythmology. Dr. Camm is also Editor of the European Society of Cardiology Textbook on Cardiovascular Medicine, Evidence Based Cardiology and Electrophysiology of the Heart. Prof Camm is also Editor-in-Chief of Clinical Cardiology.
Dr. Camm graduated from Guy’s Hospital, London and pursued a career in Cardiology at St. Bartholomew’s Hospital. In 1986, he moved to the British Heart Foundation Chair of Clinical Cardiology at St. George’s Hospital.
Liviu Klein, MD, MS
Director, Mechanical Circulatory Support and Heart Failure Device Programs, UCSF
Dr. Liviu Klein, a cardiologist at the UCSF Heart and Vascular Center, is director of the Mechanical Circulatory Support and Heart Failure Device Program. He specializes in treating patients with heart failure and arrhythmias, including patients before and after heart transplants. He also has expertise in cardiac resynchronization and mechanical therapies such as ventricular assist devices for heart failure. In his research, he studies the epidemiology of heart failure in women, including those at risk for sudden cardiac death. Together with colleagues in the department of Bioengineering and Therapeutic Sciences at UCSF, he is developing new technologies for monitoring and treating patients with cardiovascular disease (including heart failure), and for those who use ventricular assist devices.
Klein earned a medical degree at the Carol Davila School of Medicine in Bucharest, Romania, and earned a master’s of science in clinical investigation at Northwestern University in Evanston, Ill. He completed a residency in internal medicine at the Advocate Illinois Masonic Medical Center in Chicago and a fellowship in cardiovascular epidemiology at Northwestern University’s Feinberg School of Medicine. At Northwestern’s McGaw Medical Center in Chicago, he completed fellowships in cardiovascular disease, advanced heart failure and transplantation, and clinical cardiac electrophysiology. Klein is a member of the American Heart Association, Heart Failure Society of America and International Society for Lung and Heart Transplant. He has published more than 60 peer-reviewed articles and books. At UCSF, he is an associate professor of clinical medicine.
Bradley Knight, MD, FACC, FHRS
Medical Director, Cardiac Electrophysiology, Northwestern University, Feinberg School of Medicine
As the Medical Director of Cardiac Electrophysiology at Northwestern Memorial Hospital since November 2009, Dr. Knight remains clinically active with a broad range of clinical and research interests in the field of Heart Rhythm Disorders. These interests range from catheter ablation for complex arrhythmias, such as atrial fibrillation, to fundamental issues related to the basic mechanisms of various types of heart rhythm disorders, and the use of imaging in the electrophysiology laboratory to guide ablation procedures and device implantation. He is involved in several multicenter clinical trials that are evaluating novel ablation tools and implantable devices, including a totally subcutanous implantable defibrillator. He has coauthored over 250 scientific papers and is on the editorial board of several high-impact medical journals.
Frank Marshlinski, MD, FHRS
Director, Cardiac Electrophysiology Laboratory, Hospital of the University of Pennsylvania
Francis Marchlinski, MD, is a professor of medicine and serves as director of the electrophysiology program at Penn Medicine and director of the electrophysiology laboratory at the Hospital of the University of Pennsylvania. Dr. Marchlinski specializes in treating patients with heart rhythm disorders. His research interests include mechanism and ablation of atrial tachycardia and ventricular arrhythmias. Upon receiving his undergraduate degree from Pennsylvania State University, Dr. Marchlinski went on to receive his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his internship, residency and fellowship at the Hospital of the University of Pennsylvania. Dr. Marchlinski is board certified in cardiovascular medicine, electrophysiology and internal medicine.
Charles Swerdlow MD, FAHA, FACC, FHRS
Cardiac Electrophysiology, Clinical Professor of Medicine, UCLA & Cedars Sinai Medical Center
Dr. Swerdlow is a cardiac electrophysiologist specializing in the care of patients with cardiac arrhythmias. In addition to consultative and long-term patient care, his clinical interests focus in two areas: (1) catheter ablation of atrial fibrillation and other complex arrhythmias; and (2) implanted cardiac electronic devices including implantable cardioverter defibrillators (ICDs), cardiac pacemakers, cardiac resynchronization (bi-ventricular) devices, and implantable monitoring devices for heart failure.
Before moving to Los Angeles, Dr. Swerdlow served as Director of the Clinical Electrophysiology Laboratory and Director of the Cardiac Arrhythmia Study Unit at Stanford University. His previous work includes design and testing of algorithms used by ICDs to detect and differentiate arrhythmias, use of mathematical modeling to optimize electoral pulses delivered by ICDs, and development and validation of a safe and effective clinical method to determine the minimum shock strength that defibrillates the heart.
Presently, Dr. Swerdlow is an attending physician at Cedars-Sinai and Clinical Professor of Medicine at UCLA. He is a Fellow of the Heart Rhythm Society, American Heart Association, and American College of Cardiology. In addition, Dr. Swerdlow is nationally recognized for his research in clinical application of engineering principles to implantable cardiac electronic devices. According to US News and World Report, he was voted by his peers as one of the top 4 electrophysiologists in California.
He has designed and tested algorythms used by ICDs to detect and differentiate arrhythmias, used mathematical modeling to optimize electrical pulses delivered by ICDs and developed and validated a safe and effective clinical method to determine the minimum shock strength that defibrillates the heart.
As of 2011, Dr. Swerdlow was the author of 117 peer-reviewed, original scientific papers, 140 peer-reviewed abstracts, 50 chapters and review papers, and 17 issued patents. He also serves on the editorial boards of 3 cardiac electrophysiology journals.